Fiscal year 2025 executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.
Each company listed discloses IRWD in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named IRWD in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Thomas McCourt | $867,568 | $0 | $411,696 | $0 | $650,676 | $0 | $18,450 | $1,948,390 |
| Chief Executive Officer | ||||||||
| Tammi Gaskins | 474,722 | 0 | 447,777 | 0 | 274,440 | 0 | 18,450 | 1,215,389 |
| Senior Vice President, Chief Commercial Officer | ||||||||
| Gregory Martini | 470,466 | 0 | 447,777 | 0 | 274,440 | 0 | 18,450 | 1,211,133 |
| Senior Vice President, Chief Financial Officer | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| Thomas McCourt | $1,948,390 | $6,083,631 | — | −4,135,241 |
| Tammi Gaskins | 1,215,389 | — | — | — |
| Gregory Martini | 1,211,133 | — | — | — |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| Ronald Silver | PFO & PAO | 2026-05-19 | A | 25,000 | $0 | $0 | Common | Form 4 ↗ |
| Alexander Denner | Director | 2026-06-15 | A | 63,481 | 0 | 0 | Common | Form 4 ↗ |
| Alexander Denner | Director | 2026-06-15 | A | 4,065 | 0 | 0 | Common | Form 4 ↗ |
| Marla Kessler | Director | 2026-06-16 | A | 63,481 | 0 | 0 | Common | Form 4 ↗ |
| Jon Duane | Director | 2026-06-16 | A | 63,481 | 0 | 0 | Common | Form 4 ↗ |
| Mark Currie | Director | 2026-06-16 | A | 63,481 | 0 | 0 | Common | Form 4 ↗ |
| Julie McHugh | Director | 2026-06-16 | D | 21,571 | 4 | 80,460 | Common | Form 4 ↗ |
| Jay Shepard | Director | 2026-06-16 | A | 63,481 | 0 | 0 | Common | Form 4 ↗ |
| Julie McHugh | Director | 2026-06-16 | A | 63,481 | 0 | 0 | Common | Form 4 ↗ |
| Catherine Moukheibir | Director | 2026-06-16 | A | 63,481 | 0 | 0 | Common | Form 4 ↗ |
| Ronald Silver | PFO & PAO | 2026-07-07 | D | 127,890 | 5 | 578,063 | Common | Form 4 ↗ |
| Jeffrey Silber | SVP, CMO, Head-Res&Drug | 2026-07-20 | A | 137,036 | 0 | 0 | Common | Form 4 ↗ |
Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| Tammi Gaskins | RSU | 2025-01-01 | — | — | 111,111 | — | $492,222 |
| Gregory Martini | RSU | 2025-01-01 | — | — | 111,111 | — | 492,222 |
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| Tammi Gaskins | $492,222 | $0 | $0 | 0.0% |
| Gregory Martini | 492,222 | 0 | 0 | 0.0% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Gregory Martini | PSU | 111,111 | — | $374,444 |
| Tammi Gaskins | PSU | 111,111 | — | 374,444 |
| Gregory Martini | PSU | 20,475 | — | 69,001 |
| Gregory Martini | PSU | 17,810 | — | 60,020 |
| Thomas McCourt | PSU | 62,218 | — | 209,675 |
| Gregory Martini | PSU | 7,500 | — | 25,275 |
| Thomas McCourt | PSU | 80,198 | — | 270,267 |
| Thomas McCourt | Option | 442 | 369.4 | — |
| Thomas McCourt | Option | 107 | 284.2 | — |
| Thomas McCourt | Option | 205 | 320.4 | — |
| Thomas McCourt | PSU | 540,000 | — | 1,819,800 |
| Thomas McCourt | PSU | 132,438 | — | 446,316 |
| Tammi Gaskins | PSU | 20,475 | — | 69,001 |
| Tammi Gaskins | PSU | 17,810 | — | 60,020 |
| Thomas McCourt | PSU | 176,584 | — | 595,088 |
| Tammi Gaskins | PSU | 18,000 | — | 60,660 |
| Tammi Gaskins | PSU | 8,485 | — | 28,594 |
| Gregory Martini | PSU | 4,244 | — | 14,302 |
| Thomas McCourt | Option | 710 | 225.6 | — |
Our executive compensation philosophy emphasizes equity, and particularly performance-based equity, to strongly reinforce the principle of pay for performance and closely tie executive pay outcomes to stockholder value creation.
| CEO STI target (% of salary) | 75% |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Alpine Rewards LLC |
| Clawback policy | True |
| Anti-hedging | True |
| Anti-pledging | True |
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2026 | 2026-06-16 | 104,461,936 | 4,958,394 | 217,374 | 95.47% | Passed |
| 2025 | 2025-06-10 | 110,089,576 | 3,511,070 | 64,325 | 96.91% | Passed |
| 2024 | 2024-06-18 | 127,439,687 | 7,953,508 | 98,637 | 94.13% | Passed |
| 2023 | 2023-06-20 | 124,448,271 | 2,240,534 | 261,827 | 98.23% | Passed |
| 2022 | 2022-06-01 | 122,270,676 | 3,391,424 | 393,566 | 97.3% | Passed |
| 2021 | 2021-06-02 | 131,908,441 | 780,963 | 1,045,908 | 99.41% | Passed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.
| Meeting year | Meeting date | Approval — company's computation |
|---|---|---|
| 2026 | 2026-06-16 | 95.47%a |
| 2025 | 2025-06-10 | 96.91%b |
| 2024 | 2024-06-18 | 94.13%c |
a. Approved under the standard stated in the filing — “Any shares that are not voted, whether by abstention, broker non-votes or otherwise, will not affect the outcome of this proposal.”.
b. Approved under the standard stated in the filing — “Any shares that are not voted, whether by abstention, broker non-votes or otherwise, will not affect the outcome of this proposal.”.
c. Approved under the standard stated in the filing — “Any shares that are not voted, whether by abstention, broker non-votes or otherwise, will not affect the outcome of this proposal.”.
Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
| Ratio (CEO : median employee) | — |
|---|---|
| CEO total compensation | — |
| Median employee compensation | — |
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Julie McHughIndependent · Board Chair · Audit · Governance and Nominating | $101,000 | $35,960 | $0 | $0 | $0 | $136,960 |
| Catherine MoukheibirIndependent · Audit (Chair) | 75,000 | 35,960 | 0 | 0 | 0 | 110,960 |
| Andrew DreyfusIndependent · Compensation and HR (Chair) · Not standing for re-election · Departed during FY | 70,000 | 35,960 | 0 | 0 | 0 | 105,960 |
| Jon DuaneIndependent · Governance and Nominating · Compensation and HR (Chair) | 65,000 | 35,960 | 0 | 0 | 0 | 100,960 |
| Jay ShepardIndependent · Audit | 61,000 | 35,960 | 0 | 0 | 0 | 96,960 |
| Marla KesslerIndependent · Compensation and HR | 60,000 | 35,960 | 0 | 0 | 0 | 95,960 |
| Mark CurrieIndependent · Compensation and HR | 60,000 | 35,960 | 0 | 0 | 0 | 95,960 |
| Alexander DennerIndependent · Governance and Nominating (Chair) | 59,984 | 35,960 | 0 | 0 | 0 | 95,944 |
| Thomas McCourtEmployee director | 0 | 0 | 0 | — | 0 | 0 |
| Annual cash retainer | $50,000 |
|---|---|
| Annual equity retainer | $250,000 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 25,000 / 20,000 / 5,000 |
| Stock ownership guideline | 3x annual retainer ($150,000) |
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $551,984 |
| Equity awards (grant-date value) | $287,680 |
| All other compensation | $0 |
| Total cost of the board | $839,664 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Ironwood Pharmaceuticals Inc | 2025 | Thomas McCourt | $867,568 | $411,696 | $0 | $650,676 | $1,948,390 |
Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.
| # | Supports | Document | Filed | Accession | Location in document |
|---|---|---|---|---|---|
| 1 | Section 01, Thomas McCourt | DEF 14A | 2026-04-28 | 0001104659-26-050325 | Section “Summary Compensation Table”. As printed: 1,948,390. Filing ↗machine: t29 · r1 · c48 · span 584182–584191 |
| 2 | Section 01, Tammi Gaskins | DEF 14A | 2026-04-28 | 0001104659-26-050325 | Section “Summary Compensation Table”. As printed: 1,215,389. Filing ↗machine: r5 · c48 · span 605736–605745 |
| 3 | Section 01, Gregory Martini | DEF 14A | 2026-04-28 | 0001104659-26-050325 | Section “Summary Compensation Table”. As printed: 1,211,133. Filing ↗machine: r3 · c48 · span 594899–594908 |
| 4 | Section 03, Tammi Gaskins RSU | DEF 14A | — | — | Section “Executive Compensation” · grants of plan-based awards table. |
| 5 | Section 03, Gregory Martini RSU | DEF 14A | — | — | Section “Executive Compensation” · grants of plan-based awards table. |
| 6 | Section 07, pay ratio | 10-K | 2026-02-26 | 0001104659-26-020489 | Section “CEO Pay Ratio”. As printed: —. Filing ↗ |
| 7 | Section 08, Julie McHugh | DEF 14A | 2026-04-28 | 0001104659-26-050325 | Section “Director Compensation”. As printed: 136,960. Filing ↗machine: t15 · r6 · c24 · span 348093–348100 |
| 8 | Section 08, Catherine Moukheibir | DEF 14A | 2026-04-28 | 0001104659-26-050325 | Section “Director Compensation”. As printed: 110,960. Filing ↗machine: t15 · r7 · c24 · span 351245–351252 |
| 9 | Section 08, Andrew Dreyfus | DEF 14A | 2026-04-28 | 0001104659-26-050325 | Section “Director Compensation”. As printed: 105,960. Filing ↗machine: t15 · r3 · c24 · span 339545–339552 |
| 10 | Section 08, Jon Duane | DEF 14A | 2026-04-28 | 0001104659-26-050325 | Section “Director Compensation”. As printed: 100,960. Filing ↗machine: t15 · r4 · c24 · span 342245–342252 |
| 11 | Section 08, Jay Shepard | DEF 14A | 2026-04-28 | 0001104659-26-050325 | Section “Director Compensation”. As printed: 96,960. Filing ↗machine: t15 · r8 · c24 · span 354607–354613 |
| 12 | Section 08, Marla Kessler | DEF 14A | 2026-04-28 | 0001104659-26-050325 | Section “Director Compensation”. As printed: 95,960. Filing ↗machine: t15 · r5 · c24 · span 345390–345396 |
| 13 | Section 08, Mark Currie | DEF 14A | 2026-04-28 | 0001104659-26-050325 | Section “Director Compensation”. As printed: 95,960. Filing ↗machine: t15 · r1 · c24 · span 333643–333649 |
| 14 | Section 08, Alexander Denner | DEF 14A | 2026-04-28 | 0001104659-26-050325 | Section “Director Compensation”. As printed: 95,944. Filing ↗machine: t15 · r2 · c24 · span 336399–336405 |
| 15 | Section 08, Thomas McCourt | DEF 14A | 2026-04-28 | 0001104659-26-050325 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 16 | Section 02, Ronald Silver 2026-05-19 | Form 4 | 2026-05-21 | 0001193125-26-234397 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 17 | Section 02, Alexander Denner 2026-06-15 | Form 4 | 2026-06-17 | 0001193125-26-274279 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 18 | Section 02, Alexander Denner 2026-06-15 | Form 4 | 2026-06-17 | 0001193125-26-274279 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 19 | Section 02, Marla Kessler 2026-06-16 | Form 4 | 2026-06-17 | 0001193125-26-274292 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 20 | Section 02, Jon Duane 2026-06-16 | Form 4 | 2026-06-17 | 0001193125-26-274283 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 21 | Section 02, Mark Currie 2026-06-16 | Form 4 | 2026-06-17 | 0001193125-26-274288 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 22 | Section 02, Julie McHugh 2026-06-16 | Form 4 | 2026-06-17 | 0001193125-26-274275 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 23 | Section 02, Jay Shepard 2026-06-16 | Form 4 | 2026-06-17 | 0001193125-26-274301 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 24 | Section 02, Julie McHugh 2026-06-16 | Form 4 | 2026-06-17 | 0001193125-26-274275 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 25 | Section 02, Catherine Moukheibir 2026-06-16 | Form 4 | 2026-06-17 | 0001193125-26-274256 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 26 | Section 02, Ronald Silver 2026-07-07 | Form 4 | 2026-07-09 | 0001193125-26-299749 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 27 | Section 02, Jeffrey Silber 2026-07-20 | Form 4 | 2026-07-22 | 0001193125-26-312410 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 28 | Section 06, 2026 vote | Form 8-K | 2026-06-18 | 0001104659-26-075730 | Item 5.07 · say-on-pay result. As reported: 95.47% (votes for as printed: 104,461,936). Filing ↗ |
| 29 | Section 06, 2025 vote | Form 8-K | 2025-06-12 | 0001104659-25-058883 | Item 5.07 · say-on-pay result. As reported: 96.91% (votes for as printed: 110,089,576). Filing ↗ |
| 30 | Section 06, 2024 vote | Form 8-K | 2024-06-21 | 0001104659-24-073736 | Item 5.07 · say-on-pay result. As reported: 94.13% (votes for as printed: 127,439,687). Filing ↗ |
| 31 | Section 01 trend, Δ column (computed) | Computed | — | computed | Δ = current-FY total − prior-FY total per named officer.machine: formula: Δ = FY(n) − FY(n−1) |
| 32 | Section 03b vehicle mix (computed) | Computed | — | computed | RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).machine: formula: sums + PSU ratio |
| 33 | Section 09b board cost (computed) | Computed | — | computed | Cash 551,984 + equity 287,680 + all other 0 = 839,664, summed across the director compensation table rows.machine: formula: Σ = 839,664 |
| 34 | Ironwood Pharmaceuticals Inc (subject), Section 10b CEO total | DEF 14A | 2026-04-28 | 0001104659-26-050325 | CEO total compensation as printed in Ironwood Pharmaceuticals Inc's own proxy. As printed: 1,948,390. Filing ↗machine: t29 · r1 · c48 · span 584182–584191 |